Abstract:The identification of cancer driver genes (CDGs) poses challenges due to the intricate interdependencies among genes and the influence of measurement errors and noise. We propose a novel energy-constrained diffusion (ECD)-based model for identifying CDGs, termed ECD-CDGI. This model is the first to design an ECD-Attention encoder by combining the ECD technique with an attention mechanism. ECD-Attention encoder excels at generating robust gene representations that reveal the complex interdependencies among genes while reducing the impact of data noise. We concatenate topological embedding extracted from gene-gene networks through graph transformers to these gene representations. We conduct extensive experiments across three testing scenarios. Extensive experiments show that the ECD-CDGI model possesses the ability to not only be proficient in identifying known CDGs but also efficiently uncover unknown potential CDGs. Furthermore, compared to the GNN-based approach, the ECD-CDGI model exhibits fewer constraints by existing gene-gene networks, thereby enhancing its capability to identify CDGs. Additionally, ECD-CDGI is open-source and freely available. We have also launched the model as a complimentary online tool specifically crafted to expedite research efforts focused on CDGs identification. Cancer has become a major disease threatening human life and health. Cancer usually originates from abnormal gene activities, such as mutations and copy number variations. Mutations in cancer driver genes are crucial for the selective growth of tumor cells. Identifying cancer driver genes is crucial in cancer-related research and treatment strategies, as it helps understand cancer occurrence and development. However, the complex gene-gene interactions, measurement errors, and the prevalence of unlabeled data significantly complicate the identification of these driver genes. We developed a new method that integrates an energy-constrained diffusion mechanism with an attention mechanism to uncover implicit gene dependencies in biomolecular networks and generate robust gene representations. Extensive experiments demonstrated that our model accurately identifies known cancer driver genes and effectively discovers potential ones. Furthermore, we analyzed and predicted patient-specific mutated genes, enhancing our understanding of their pathogenesis and advancing precision medicine. In summary, our method offers a promising tool for advancing the identification of cancer driver genes.

HIV Infection, the Brain and Behaviour: Major Psychiatric Disorder without Cognitive Impairment before or after the Episode

SYSTEMATIC ASSESSMENT OF ANALYTICAL METHODS FOR DRUG SENSITIVITY PREDICTION FROM CANCER CELL LINE DATA

Accelerating Complex Disease Treatment through Network Medicine and GenAI: A Case Study on Drug Repurposing for Breast Cancer

maGENEgerZ: An Efficient Artificial Intelligence-Based Framework Can Extract More Expressed Genes and Biological Insights Underlying Breast Cancer Drug Response Mechanism

Network-based estimation of therapeutic efficacy and adverse reaction potential for prioritisation of anti-cancer drug combinations

Dose-response modeling in high-throughput cancer drug screenings: An end-to-end approach

Comprehensive information-based differential gene regulatory networks analysis (CIdrgn): Application to gastric cancer and chemotherapy-responsive gene network identification

Exploring Gene Regulatory Interaction Networks and predicting therapeutic molecules for Hypopharyngeal Cancer and EGFR-mutated lung adenocarcinoma

maGENEgerZ: An Efficient AI-Based Framework Can Extract More Expressed Genes and Biological Insights Underlying Breast Cancer Drug Response Mechanism

A Network Science Approach to Driver Gene Detection In Human Regulatory Network Using Genes Influence Evaluation

DataXflow: Synergizing Data-Driven Modeling with Best Parameter Fit and Optimal Control – An efficient data analysis for Cancer research

A Reverse Engineering Approach to Optimize Experiments for the Construction of Biological Regulatory Networks

Elucidation of differential response networks from toxicogenomics data

Major rat brain membrane‐associated and cytosolic enkephalin‐degrading aminopeptidases: Comparison studies

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer

ECD-CDGI: An efficient energy-constrained diffusion model for cancer driver gene identification

Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer.

Smell Detection Agent Optimisation Framework and Systems Biology Approach to Detect Dys-Regulated Subnetwork in Cancer Data

Advancing cancer driver gene identification through an integrative network and pathway approach

Anticancer Target Combinations: Network-Informed Signaling-Based Approach to Discovery

Developing Anticancer Drug Response System Using Deep Learning System with Hybrid Genomic and Chemical Features